HCPLive Network

Alzheimer's Disease

A new blood test said to predict Alzheimer’s disease up to 10 years before its onset will be available to researchers and pharmaceutical companies this fall, according to NanoSomiX, the company that developed it.
Benzodiazepine use is associated with an increased risk of Alzheimer's disease, with exposure density correlating with increased strength of association, according to a study published online Sept. 9 in BMJ.
Even though the active ingredient in marijuana can be associated with memory impairment, it may slow or halt Alzheimer’s disease.
Cerebrospinal fluid biomarkers for Alzheimer's disease, particularly β-amyloid 42 (Aβ42), are strongly associated with AD diagnosis, independent of APOE genotype, according to a study published online Aug. 27 in JAMA Psychiatry.
Researchers have manufactured a peptide aimed to block modified proteins associated with Alzheimer’s disease, Parkinson’s disease, heart disease, type 2 diabetes, Lou Gehrig’s disease, and other conditions.
The association between obesity and subsequent dementia varies with the age at which obesity is first recorded, according to a study published online Aug. 20 in the Postgraduate Medical Journal.
Alzheimer's Disease Upcoming Events
Mesa, AZ
February 28, 2014
Keystone, CO
March 2-7, 2014
Charleston, SC
March 14-16, 2014
Copenhagen, Denmark
July 12-17, 2014
Taos, New Mexico
January 25-30, 2015
Nice, France
March 18-22, 2015
Perth, Australia
April 15-18, 2015
Seattle, WA
April 16, 2015
Washington, DC
July 18-23, 2015
Alzheimer's Disease Latest News
Alzheimer's Disease Clinical Trials
Alzheimer's Disease Resources